斯洛文尼亚轮状病毒疫苗对住院保护效果研究
斯洛文尼亚2019-2023年出生队列研究显示,轮状病毒疫苗全程接种率为25%,部分接种率4%。全程接种对轮状病毒相关住院的疫苗有效性为84%(95%CI:73%-91%),部分接种为81%(95%CI:42%-94%)。全程接种率与住院率呈负相关(r=-0.155,p=0.024),支持将轮状病毒疫苗纳入国家免疫规划。
要点
- 全程接种轮状病毒疫苗对住院的保护效果为84%(95%CI:73%-91%)。
- 部分接种亦有效,疫苗有效性为81%(95%CI:42%-94%)。
- 全程接种率与住院率呈负相关(r=-0.155,p=0.024)。
核心结论
- 全程和部分接种轮状病毒疫苗均显著减少斯洛文尼亚儿童轮状病毒相关住院。
- 研究结果支持提高疫苗接种率并考虑将轮状病毒疫苗纳入国家免疫规划。
研究设计与样本
- 链接斯洛文尼亚人口登记、疫苗接种、监测和住院数据库,纳入2019-2023年出生队列。
- 共纳入89994名儿童,采用准泊松回归估计疫苗有效性,调整年龄、医疗可及性、社会经济状况和日历时间。
主要发现
- 全程接种率为25%,部分接种率为4%;共发生1272例轮状病毒住院,其中94%为未接种儿童。
- 全程接种疫苗有效性为84%(95%CI:73%-91%),部分接种为81%(95%CI:42%-94%)。
- RV1疫苗有效性为85%(95%CI:74%-91%),RV5为78%(95%CI:-29%-96%)。
- 11月龄以下儿童疫苗有效性为73%(95%CI:30%-89%),11-23月龄为88%(95%CI:76%-94%),5岁前持续高效(84%,95%CI:63%-93%)。
- 全程接种率与住院率在市政区间呈负相关(r=-0.155,p=0.024)。
临床怎么用
- 应努力提高轮状病毒疫苗接种率以降低儿童住院负担。
- 政策制定者可考虑将轮状病毒疫苗纳入国家免疫规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Slovenia, coverage of rotavirus vaccines (Rotarix (RV1) and RotaTeq (RV5)) remains low, and the vaccines are not included in the National Vaccination Programme (NVP). We aimed to estimate vaccine effectiveness (VE) against rotavirus-related hospitalization among children aged 6 weeks to 5 years to inform national vaccination policy. METHODS: We linked Slovenian population registry with vaccination, surveillance, and hospitalization databases for 2019-2023 birth cohorts. We defined fully vaccinated as those receiving all recommended doses with the last dose ≥14 days before the end date (disease onset or hospitalization date, death, or study end) and partially vaccinated those receiving ≥1 dose ≥14 days before the end date. We estimated VE using quasi-Poisson regression, adjusting for age, healthcare access, socioeconomic status, and calendar time, with person-time at risk included as an offset. We also examined the relationship between full vaccination coverage and hospitalization rates across municipalities using Pearson's correlation coefficient. RESULTS: Among 89,994 children, 4% were partially, and 25% fully vaccinated. A total of 1272 rotavirus hospitalizations occurred, 94% among unvaccinated children. VE against hospitalization was 84% (95% CI: 73%-91%) for full and 81% (95% CI: 42%-94%) for partial vaccination. VE was 85% (95% CI: 74%-91%) for RV1 and 78% (95% CI: -29%-96%) for RV5. VE was 73% (95% CI: 30%-89%) among children aged <11 months and 88% (95% CI: 76%-94%) among those aged 11 to 23 months, with sustained high effectiveness through 5 years of age (84%, 95% CI: 63%-93%). We observed a negative correlation between full vaccination coverage and hospitalization rates across municipalities (r = -0.155, p = 0.024). CONCLUSION: Both full and partial rotavirus vaccination significantly reduced rotavirus-related hospitalizations among children in Slovenia. These findings support efforts to improve vaccine uptake and consideration of rotavirus vaccination inclusion in the NVP to reduce disease burden.
引用
- Mrzel M, Danis K, Učakar V, et al. Low uptake rotavirus vaccine: A study of vaccine effectiveness against rotavirus-related hospitalization based on electronic health records, Slovenia, 2019-2023. Vaccine. 2026. PMID: 41825192. doi:10.1016/j.vaccine.2026.128440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。